This year’s annual meeting of the American Society of Clinical Oncology (ASCO), which ended on Tuesday, provided many examples of emerging therapies that offer new hope to even those patients with metastatic disease.
John Otrompke
Advertisement
Articles by John Otrompke
Advertisement
Latest Updated Articles
- Drug Innovation: Alive and Well at ASCO!
June 6th 2012
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Moving CAR-T Beyond Oncology
3
Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development
4
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
5